Ravi Viswanathan, 10% Owner at Tracon Pharmaceuticals, Inc. (TCON), bought 1,415,928 shares at $2.70 ($3.8M) on 2018-03-27, disclosed to the SEC on 2018-03-27.
Open-market purchase of $3.8M TCON by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.70 | 707,964 | $1.9M | 50.0% |
| 2 | $2.70 | 707,964 | $1.9M | 50.0% |
| Total | $2.70 avg | 1,415,928 | $3.8M | 100% |
| Filing → |
| AVEO | BUY | 2018-07-20 | $491K | — | Filing → |
| AVEO | BUY | 2018-06-28 | $404K | — | Filing → |
| AVEO | BUY | 2018-05-30 | $591 | — | Filing → |